107285-64-3 Usage
Uses
Used in Medical Device Coating Industry:
2-Oxetanecarboxylic acid, 4-oxo-, ethyl ester, (2R)-(9CI) is used as a monomer in the production of copolymers for coating materials. These copolymers are specifically designed for use in the medical device industry, where they provide protective coatings that enhance the performance and durability of various medical devices. The unique properties of this compound, such as its chirality and oxetane ring structure, contribute to the development of copolymers with improved characteristics, making them suitable for use in the medical field.
Used in Pharmaceutical Industry:
Although not explicitly mentioned in the provided materials, the compound's unique structure and chirality may also make it a potential candidate for use in the pharmaceutical industry. It could be utilized in the development of novel drugs or drug delivery systems, taking advantage of its specific stereochemistry to target specific biological receptors or pathways. Further research and development would be required to explore these potential applications fully.
Check Digit Verification of cas no
The CAS Registry Mumber 107285-64-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,2,8 and 5 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 107285-64:
(8*1)+(7*0)+(6*7)+(5*2)+(4*8)+(3*5)+(2*6)+(1*4)=123
123 % 10 = 3
So 107285-64-3 is a valid CAS Registry Number.
107285-64-3Relevant articles and documents
Chiral dirhodium(II) carboxamidate-catalyzed [2 + 2]-cycloaddition of TMS-ketene and ethyl glyoxylate
Forslund, Raymond E.,Cain, James,Colyer, John,Doyle, Michael P.
, p. 87 - 92 (2007/10/03)
The [2 + 2]-cycloaddition reaction between ethyl glyoxylate and trimethylsilylketene is reported. Enantiomeric excesses up to 83% have been achieved with the use of only 1.0 mol % of a previously unreported chiral imidazolidinone-ligated dirhodium(II) carboxamidate catalyst. An extensive survey of chiral catalysts has shown that enantiocontrol for cycloaddition increases as the steric bulk of the ligand is increased. However, enantioselectivity is increased to 99% ee by the addition of 10 mol % of quinine as a co-catalyst with a chiral dirhodium(II) azetidinone-ligated catalyst, and there is a significant decrease in reaction time.
C2-Symmetric Cu(II) Complexes as Chiral Lewis Acids. Catalytic, Enantioselective Cycloadditions of Silyl Ketenes
Evans, David A.,Janey, Jacob M.
, p. 2125 - 2128 (2007/10/03)
(matrix presented) C2-Symmetric bis(oxazoline)-Cu(II) complexes (4a-g) catalyze the enantioselective [2 + 2] cycloaddition between (silyl)ketenes and chelating carbonyl substrates. A range of substituted β-lactones can be produced in excellent yields and selectivities. It was also found that (trimethylsilyl)-ketene (1) may also undergo a highly selective hetero Diels-Alder reaction with β,γ-unsaturated α-keto esters.
